AstroNova, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data AstroNova, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	98.4	113	137	133	116	117	143	148	151	151
Cost of revenue	59	69.4	82.7	84.7	74.7	73.7	94.4	98.6	101	103
Gross profit	39.5	44	54	48.8	41.4	43.7	48.2	49.5	50.7	47.6
Research and development	6.31	7.45	7.81	8.08	6.21	6.75	6.82	6.34	6.05	6.79
Selling and marketing	19	22.2	26.3	26.9	23.3	23.2	24.5	23.4	24.3	23
General and administrative	7.94	8.9	11.1	11.4	9.42	9.55	11.4	11	15.6	16.4
Operating expenses	33.2	38.6	45.3	46.3	38.9	39.5	42.7	40.7	59.3	46.4
Operating income	6.28	5.41	8.72	2.43	2.43	4.26	5.44	8.8	-8.64	1.21
Interest expense		0.4	0.6	0.68	0.96	0.68	1.68	2.7	3.21	3.5
Other non-operating income	0.32	-0.26	-1.41	-1.06	-0.25	2.78	-2.03	-2.72	-3.65	-3.74
Pre-tax income	6.61	5.16	7.31	1.37	2.18	7.03	3.41	6.07	-12.3	-2.54
Income tax	2.38	1.87	1.58	-0.39	0.9	0.61	0.75	1.38	2.2	-0.16
Net income	4.23	3.29	5.73	1.76	1.28	6.43	2.66	4.69	-14.5	-2.38
EBITDA	8.71	9.41	14.9	8.72	8.42	8.25	9.36	13.1	-3.86	6.01
EPS, basic	0.57	0.48	0.83	0.25	0.18	0.89	0.36	0.63	-1.93	-0.31
EPS, diluted	0.56	0.47	0.81	0.24	0.18	0.88	0.36	0.63	-1.93	-0.31
Shares, basic (weighted)	7.42	6.91	6.88	7.02	7.1	7.21	7.31	7.42	7.51	7.61
Shares, diluted (weighted)	7.57	7.02	7.08	7.24	7.17	7.34	7.37	7.5	7.51	7.61
Dividend per share	0.28	0.28	0.07	0.28	0.07

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	18.1	10.2	7.53	4.25	11.4	5.28	3.95	4.53	5.05	4.07
Short-term investments	6.72	1.51
Receivables	15.7	22.4	23.5	19.8	17.4	17.1	21.6	23.1	21.2	19
Inventory	19.5	27.6	30.2	33.9	30.1	34.6	51.3	46.4	47.9	43.3
Other current assets	1.39	1.25	1.43	2.19	1.81	3.63	2.89	2.72	3.86	4.4
Total current assets	61.4	62.9	62.6	60.2	60.7	63.8	79.8	76.7	78	70.7
Property, plant and equipment	9.28	9.75	10.4	11.3	12	11.4	14.3	14.2	15.8	14.1
Lease right-of-use assets				1.66	1.39	1.09	0.79	0.6	1.78	2.47
Goodwill	4.52	13	12.3	12	12.8	12.2	14.7	14.6	16.4	17.4
Intangible assets	5.26	33.6	29.7	25.4	21.5	19.2	21.2	18.8	23.5	21.5
Other non-current assets	13	49.6
Total assets	83.7	122	119	117	115	115	139	133	146	138
Accounts payable	4.96	11.8	5.96	4.41	5.73	8.59	8.48	8.07	7.93	6.81
Accrued liabilities	2.17	2.41	2.91	4.71	3.87	4.11	3.31	2.71	4.46	4.7
Deferred revenue	0.47	0.37	0.37	0.47	0.26	0.26	0.41	0.53	0.54	0.49
Short-term debt		5.5	5.21	5.21	5.33	1	2.1	2.84	6.11	3.03
Total current liabilities	12	25.9	24.7	26.8	21	20	37.5	29.8	46.3	38.4
Long-term debt		17.6	12.9	7.72	7.11	8.15	12	10.1	19	18.3
Lease liabilities				1.28	1.07	0.81	0.56	0.42	1.54	1.95
Other non-current liabilities	1.13	2.65	1.72	1.08	0.68	0.4			0	0.24
Total liabilities	13.1	58.7	49.2	45.3	40.8	33.9	54.8	43	69.8	60.7
Total debt		23.1	18.1	12.9	12.4	9.15	14.1	12.9	25.2	21.3
Paid-in capital	47.5	50	53.6	56.1	58	59.7	61.1	62.7	64.2	66.3
Retained earnings	44.4	45.7	49.5	49.3	50.1	56.5	59.2	63.9	49.4	47
Treasury stock	-20.8	-32.4	-33	-33.5	-33.6	-34	-34.2	-34.6	-35	-35.2
Other comprehensive income	-1.06	-0.17	-0.82	-1.09	-0.38	-1.75	-2.24	-2.22	-3.35	-1.8
Shareholders' equity	70.5	63.6	69.8	71.4	74.7	81	84.4	90.3	75.8	76.9
Total equity	70.5	63.6	69.8	71.4	74.7	81	84.4	90.3	75.8	76.9
Total liabilities and equity	83.7	122	119	117	115	115	139	133	146	138

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	4.23	3.29	5.73	1.76	1.28	6.43	2.66	4.69	-14.5	-2.38
Depreciation and amortization	2.43	3.99	6.15	6.28	5.98	3.99	3.92	4.27	4.78	4.8
Stock-based compensation	1.02	1.58	1.89	1.78	1.82	1.49	1.29	1.35	1.38	2.31
Deferred income tax	0.17	0.74	-1.64	-1.64	-1.02	0.21	-1.34	-0.08	0.79	-1.39
Change in receivables	-0.42	-4.72	-1.49	3.59	2.7	0.08	-1.23	-1.49	2.86	2.79
Change in inventory	-4.66	-5.51	-2.87	-3.94	4.25	-4.88	-11.6	2.91	1.62	5.91
Change in payables	1.43	5.21	-2.34	-2.73	-0.06	4.05	-3.24	-0.05	-2.38	-1.13
Cash from operations	6.95	3.72	5.01	3.22	15.5	1.39	-2.94	12.4	4.85	11.7
Capital expenditures	-1.24	-2.2	-2.65	-2.91	-2.59	-1.8	-0.23	-0.88	-1.17	-0.33
Acquisitions		-9.01
Cash from investing	3.12	-20.8	-1.53	-2.91	-2.59	-1.8	-17.3	-0.88	-20.3	-0.22
Debt issued		24.2			15.2	10	6	0	15.1	19.7
Debt repaid		-0.83	-5.13	-5.21	-3.96
Share buybacks		-11.2
Dividends paid	-2.08	-1.94	-1.93	-1.97	-0.5
Cash from financing	-2	9.06	-6.11	-3.74	-5.14	-5.56	18.8	-11	15.4	-12.9
Exchange rate effect	-0.02	0.08	-0	0.14	-0.63	-0.21	0.11	0.07	0.57	0.36
Net change in cash	8.06	-7.92	-2.64	-3.29	7.19	-6.16	-1.33	0.58	0.52	-0.98
Free cash flow	5.72	1.52	2.36	0.32	13	-0.4	-3.17	11.5	3.68	11.4
Interest paid		0.25	0.64	0.53	0.68	0.34	0.79	2.34	2.7	3.04
Income taxes paid	-0.08	1.94	3.47	2.91	0.45	2.41	0.31	1.69	2.21	0.63

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to April 30, 2026; growth uses fiscal years. Valuation uses the share price of $28.99 on August 26, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	32.9%	Gross profit / revenue.
Operating margin	1.4%	Operating income / revenue.
EBITDA margin	3.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-0.9%	Pre-tax income / revenue.
Net margin	-0.9%	Net income / revenue.
FCF margin	6.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	6.8%	Cash from operations / revenue.
Return on equity (ROE)	-1.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-1.0%	Net income / average total assets.
Return on invested capital (ROIC)	1.9%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	4.6%	Research and development expense / revenue.
Stock-based pay / revenue	1.6%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.2%	Capital expenditures / revenue.
D&A / revenue	2.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-0.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	1.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	5.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-6.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-0.4%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	2.9%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income CAGR, 3y	-39.5%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-13.1%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA CAGR, 3y	-13.7%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-6.5%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	142.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y	-5.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	209.7%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	-2.5%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	1.5%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-3.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	0.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-5.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-0.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	3.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	1.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	1.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.76x	Current assets / current liabilities.
Quick ratio	0.62x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.11x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.26x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	14.7%	Total debt / total assets.
Liabilities / assets	44.6%	Total liabilities / total assets.
Net debt	$15.8M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.90x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	0.67x	Operating income / interest expense.
Working capital	$32.3M	Current assets - current liabilities.
Goodwill and intangibles / assets	27.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	$39.6M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.09x	Revenue / average total assets.
Fixed asset turnover	11.2x	Revenue / average property, plant and equipment.
Inventory turnover	2.34x	Cost of revenue / average inventory.
Days inventory	156 days	365 x average inventory / cost of revenue.
Receivables turnover	7.04x	Revenue / average receivables.
Days sales outstanding	52 days	365 x average receivables / revenue.
Days payables	27 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	181 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	3.0%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.17	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$19.57	Revenue / diluted weighted shares.
FCF per share	$1.29	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.33	Cash from operations / diluted weighted shares.
Book value per share	$9.97	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$5.09	Tangible book value / shares outstanding.
Cash per share	$0.60	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$224.6M	Share price x shares outstanding.
Enterprise value	$240.4M	Market cap + total debt - cash - short-term investments.
P/S	1.48x	Market cap / revenue.
P/B	2.90x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	5.67x	Market cap / tangible book value, when positive.
P/FCF	22.3x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	21.7x	Market cap / cash from operations, when positive.
EV/Sales	1.58x	Enterprise value / revenue.
EV/EBIT	109x	Enterprise value / operating income, when both are positive.
EV/EBITDA	44.1x	Enterprise value / EBITDA, when both are positive.
EV/FCF	23.9x	Enterprise value / free cash flow, when both are positive.
FCF yield	4.5%	Free cash flow / market cap.
Earnings yield	-0.6%	Net income / market cap (the inverse of P/E).

What was AstroNova, Inc.'s revenue in fiscal 2026?

AstroNova, Inc. reported revenue of $150.5M for fiscal 2026, 0.5% lower than the year before.

Was AstroNova, Inc. profitable in fiscal 2026?

No. It reported a net loss of $2.4M.

How much free cash flow did AstroNova, Inc. generate in fiscal 2026?

Cash from operations of $11.7M minus capital expenditures of $332.0K left free cash flow of $11.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to AstroNova, Inc.